Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 4.02 MB)

  Published:

  28 April 2021

• Final appraisal determination committee papers (PDF 852 KB)

  Published:

  28 April 2021